Why is the Pentagon making Ebola ‘therapeutic’ and CDC Patenting Ebola strains?

Sunday, October 26, 2014
By Paul Martin

William Engdahl
Journal-neo.org
26.10.2014

The growing Ebola panic, being deliberately fanned by the criminally-irresponsible Dr Margaret Chan, the notorious “Swine Flu Pandemic” Director General of WHO in Geneva, and by the criminally irresponsible officials of the US Government Centers for Disease Control (CDC), is getting more and more absurd and more destructive by the day.

Not only do the official WHO “Ebola symptoms” list symptoms of common influenza or even severe colds. Not only is the only recognized “accurate laboratory test” for Ebola, the Kary Mullis PCR test identified by its inventor (for an entirely other purpose) Nobel Prize winning Dr Kary Mullis as utterly worthless to detect Ebola in a body. In an interview Mullis stated, “Quantitative PCR is an oxymoron.” PCR is intended to identify substances qualitatively, but by its very nature is unsuited for estimating numbers. The tests can detect genetic sequences of viruses, but not viruses themselves.

Now we discover that a new company has gone into partnership with the Pentagon…to produce “an anti-Ebola virus RNAi therapeutic” (sic). On August 4, the US TV channel, Fox News carried this intriguing lead: “The experimental drug used to treat two American aid workers who have been infected with the Ebola virus has never been tested on humans before and was only identified earlier this year as part of an ongoing research program backed by the U.S. government and military…The Defense Department has long had a hand in researching infectious diseases, including Ebola.”

DOD and Tekmira

Further research has since uncovered the following highly fascinating and highly suspicious fact about that ongoing US Department of Defense Ebola research program.

It seems the US Defense Department has joined with a biotech company named Tekmira Pharmaceuticals Corporation. Its stock is listed on NASDAQ under TKMR. Tekmira labels itself as a leading developer of RNA interference (RNAi) therapeutics. Since the Ebola scare, the stock price has shot through the roof, much like Don Rumsfeld’s shares in Gilead Sciences, inventor of the Tamiflu soared after Defense Secretary Rumsfeld ordered $1 billion worth of the worthless Tamiflu for his soldiers against an earlier fake flu scare, Bird Flu.

The Rest…HERE

Leave a Reply

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter